Chemical Formula: C32H36N4O3

Chemical Formula C32H36N4O3

Found 16 metabolite its formula value is C32H36N4O3

   

Okaramine C

Okaramine C

C32H36N4O3 (524.2787266)


An indole alkaloid isolated from Penicillium simplicissimum. It exhibits insecticidal activity.

   
   
   

(3S)-3beta-[2-(1,1-Dimethyl-2-propenyl)-1H-indole-3-ylmethyl]-6-(1,1-dimethyl-2-propenyl)-2,3,4,5aalpha,6,10b,11,11aalpha-octahydro-10balpha-hydroxy-1H-pyrazino[1,2:1,5]pyrrolo[2,3-b]indole-1,4-dione

(3S)-3beta-[2-(1,1-Dimethyl-2-propenyl)-1H-indole-3-ylmethyl]-6-(1,1-dimethyl-2-propenyl)-2,3,4,5aalpha,6,10b,11,11aalpha-octahydro-10balpha-hydroxy-1H-pyrazino[1,2:1,5]pyrrolo[2,3-b]indole-1,4-dione

C32H36N4O3 (524.2787266)


   
   

BIBS 39

BIBS 39

C32H36N4O3 (524.2787266)


BIBS 39 is a new nonpeptide angiotensin II (AII) receptor antagonist. Target: Angiotensin Receptor in vitro: BIBS 39 displaces [125I] AII from its specific binding sites with a Ki value of 29 ± 7 nM for the AII subtype 1 (AT1) receptor and a Ki value of 480 ± 110 nM for the AII subtype 2 (AT2) receptor. BIBS 222 shows a Ki value of 20 ± 7 nM for the AT1 subtype and a Ki value of 730 ± 170 nM for the AT2 subtype. BIBS 39 is 17 times more selective for the AT1 subtype and BIBS 222 37 times. BIBS 39 shifts the AII concentration-contractile response curves in isolated rabbit aorta to the right in a parallel fashion. [1] in vivo: In pithed rats, BIBS 39 dependently shifts the dose-response curve of AII to the right without affecting the maximal response. BIBS 222 also causes parallel shifts to the right but a significant reduction of the maximal responses was observed at 3 and 10 mg/kg i.v. These results show that the benzimidazole derivatives BIBS 39 is a potent and selective AII receptor antagonists. Substitution with a benzimidazole moiety results into a considerable loss of selectivity for the AT1 receptor subtype compared with an imidazole moiety as, for instance, in DuP 753.[1] BIBS 39 is a new nonpeptide angiotensin receptor blockers that has affinity for both AT1- and AT2-receptors, is also a potent antagonist of the cardiovascular effects of AII in pithed rabbits. [2]

   

(1r,4s,7s,9s)-6,9-dihydroxy-16-(2-methylbut-3-en-2-yl)-4-{[2-(2-methylbut-3-en-2-yl)-1h-indol-3-yl]methyl}-2,5,16-triazatetracyclo[7.7.0.0²,⁷.0¹⁰,¹⁵]hexadeca-5,10,12,14-tetraen-3-one

(1r,4s,7s,9s)-6,9-dihydroxy-16-(2-methylbut-3-en-2-yl)-4-{[2-(2-methylbut-3-en-2-yl)-1h-indol-3-yl]methyl}-2,5,16-triazatetracyclo[7.7.0.0²,⁷.0¹⁰,¹⁵]hexadeca-5,10,12,14-tetraen-3-one

C32H36N4O3 (524.2787266)


   

(1s,7r,9r)-6,9-dihydroxy-16-(2-methylbut-3-en-2-yl)-4-{[2-(2-methylbut-3-en-2-yl)-1h-indol-3-yl]methyl}-2,5,16-triazatetracyclo[7.7.0.0²,⁷.0¹⁰,¹⁵]hexadeca-5,10,12,14-tetraen-3-one

(1s,7r,9r)-6,9-dihydroxy-16-(2-methylbut-3-en-2-yl)-4-{[2-(2-methylbut-3-en-2-yl)-1h-indol-3-yl]methyl}-2,5,16-triazatetracyclo[7.7.0.0²,⁷.0¹⁰,¹⁵]hexadeca-5,10,12,14-tetraen-3-one

C32H36N4O3 (524.2787266)


   

6,9-dihydroxy-14-(3-methylbut-2-en-1-yl)-4-{[2-(2-methylbut-3-en-2-yl)-1h-indol-3-yl]methyl}-2,5,16-triazatetracyclo[7.7.0.0²,⁷.0¹⁰,¹⁵]hexadeca-5,10,12,14-tetraen-3-one

6,9-dihydroxy-14-(3-methylbut-2-en-1-yl)-4-{[2-(2-methylbut-3-en-2-yl)-1h-indol-3-yl]methyl}-2,5,16-triazatetracyclo[7.7.0.0²,⁷.0¹⁰,¹⁵]hexadeca-5,10,12,14-tetraen-3-one

C32H36N4O3 (524.2787266)


   

(1r,4s,7s,9s)-6,9-dihydroxy-16-(3-methylbut-2-en-1-yl)-4-{[2-(2-methylbut-3-en-2-yl)-1h-indol-3-yl]methyl}-2,5,16-triazatetracyclo[7.7.0.0²,⁷.0¹⁰,¹⁵]hexadeca-5,10,12,14-tetraen-3-one

(1r,4s,7s,9s)-6,9-dihydroxy-16-(3-methylbut-2-en-1-yl)-4-{[2-(2-methylbut-3-en-2-yl)-1h-indol-3-yl]methyl}-2,5,16-triazatetracyclo[7.7.0.0²,⁷.0¹⁰,¹⁵]hexadeca-5,10,12,14-tetraen-3-one

C32H36N4O3 (524.2787266)


   

6,9-dihydroxy-16-(2-methylbut-3-en-2-yl)-4-{[2-(2-methylbut-3-en-2-yl)-1h-indol-3-yl]methyl}-2,5,16-triazatetracyclo[7.7.0.0²,⁷.0¹⁰,¹⁵]hexadeca-5,10,12,14-tetraen-3-one

6,9-dihydroxy-16-(2-methylbut-3-en-2-yl)-4-{[2-(2-methylbut-3-en-2-yl)-1h-indol-3-yl]methyl}-2,5,16-triazatetracyclo[7.7.0.0²,⁷.0¹⁰,¹⁵]hexadeca-5,10,12,14-tetraen-3-one

C32H36N4O3 (524.2787266)


   

(1s,4r,7r,9s)-6,9-dihydroxy-1-(2-methylbut-3-en-2-yl)-4-{[2-(2-methylbut-3-en-2-yl)-1h-indol-3-yl]methyl}-2,5,16-triazatetracyclo[7.7.0.0²,⁷.0¹⁰,¹⁵]hexadeca-5,10,12,14-tetraen-3-one

(1s,4r,7r,9s)-6,9-dihydroxy-1-(2-methylbut-3-en-2-yl)-4-{[2-(2-methylbut-3-en-2-yl)-1h-indol-3-yl]methyl}-2,5,16-triazatetracyclo[7.7.0.0²,⁷.0¹⁰,¹⁵]hexadeca-5,10,12,14-tetraen-3-one

C32H36N4O3 (524.2787266)


   

6,9-dihydroxy-16-(3-methylbut-2-en-1-yl)-4-{[2-(2-methylbut-3-en-2-yl)-1h-indol-3-yl]methyl}-2,5,16-triazatetracyclo[7.7.0.0²,⁷.0¹⁰,¹⁵]hexadeca-5,10,12,14-tetraen-3-one

6,9-dihydroxy-16-(3-methylbut-2-en-1-yl)-4-{[2-(2-methylbut-3-en-2-yl)-1h-indol-3-yl]methyl}-2,5,16-triazatetracyclo[7.7.0.0²,⁷.0¹⁰,¹⁵]hexadeca-5,10,12,14-tetraen-3-one

C32H36N4O3 (524.2787266)


   

(1r,4s,7s,9s)-6,9-dihydroxy-14-(3-methylbut-2-en-1-yl)-4-{[2-(2-methylbut-3-en-2-yl)-1h-indol-3-yl]methyl}-2,5,16-triazatetracyclo[7.7.0.0²,⁷.0¹⁰,¹⁵]hexadeca-5,10,12,14-tetraen-3-one

(1r,4s,7s,9s)-6,9-dihydroxy-14-(3-methylbut-2-en-1-yl)-4-{[2-(2-methylbut-3-en-2-yl)-1h-indol-3-yl]methyl}-2,5,16-triazatetracyclo[7.7.0.0²,⁷.0¹⁰,¹⁵]hexadeca-5,10,12,14-tetraen-3-one

C32H36N4O3 (524.2787266)


   

(1s,4s,7r,9r)-6,9-dihydroxy-16-(2-methylbut-3-en-2-yl)-4-{[2-(2-methylbut-3-en-2-yl)-1h-indol-3-yl]methyl}-2,5,16-triazatetracyclo[7.7.0.0²,⁷.0¹⁰,¹⁵]hexadeca-5,10,12,14-tetraen-3-one

(1s,4s,7r,9r)-6,9-dihydroxy-16-(2-methylbut-3-en-2-yl)-4-{[2-(2-methylbut-3-en-2-yl)-1h-indol-3-yl]methyl}-2,5,16-triazatetracyclo[7.7.0.0²,⁷.0¹⁰,¹⁵]hexadeca-5,10,12,14-tetraen-3-one

C32H36N4O3 (524.2787266)